ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,684Medicare Part D Prescriptions Filled, Including Refills

Rank: 171 out of 1206

$502K Total Retail Price of All Prescriptions

Rank: 166 out of 1206

340 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,810 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
HYDROCODONE-ACETAMINOPHEN 693 339 S3 1 7
OMEPRAZOLE 409 285 2 3
SIMVASTATIN 405 382 3 1
FUROSEMIDE 380 302 4 5
LEVOTHYROXINE SODIUM 321 282 5 2
AMLODIPINE BESYLATE 257 214 6 6
METOPROLOL TARTRATE 208 187 7 9
CITALOPRAM HBR 195 126 8 16
HYDROCHLOROTHIAZIDE 185 178 9 11
METFORMIN HCL 179 117 10 10
LISINOPRIL 154 139 11 4
DONEPEZIL HCL 151 151 12 29
FENTANYL 149 43 S2 13 51
SERTRALINE HCL 149 129 13 22
POTASSIUM CHLORIDE 141 111 15 12
ENALAPRIL MALEATE 139 103 16 45
PRAVASTATIN SODIUM 134 94 17 21
NAMENDA 132 129 18 36
WARFARIN SODIUM 131 111 19 8
ATENOLOL 117 95 20 14
BUSPIRONE HCL 112 88 21 110
TRAZODONE HCL 102 59 22 37
CEPHALEXIN 90 81 23 62
GLIMEPIRIDE 88 73 24 34
ATORVASTATIN CALCIUM 87 72 25 13
OXYCODONE HCL 86 0 S2 26 107
POLYETHYLENE GLYCOL 3350 86 80 26 31
ZOLPIDEM TARTRATE 86 51 26 25
RANITIDINE HCL 84 67 29 23
TAMSULOSIN HCL 80 59 30 26
JANTOVEN 74 74 31 95
PAROXETINE HCL 72 72 32 53
VENLAFAXINE HCL ER 70 37 33 89
ALENDRONATE SODIUM 69 66 34 19
GLIPIZIDE ER 69 55 34 99
LEVETIRACETAM 68 65 36 135
PREDNISONE 67 42 37 28
MIRTAZAPINE 66 63 38 50
ESCITALOPRAM OXALATE 64 53 39 86
ALLOPURINOL 62 56 40 24
AZITHROMYCIN 62 33 40 46
TOPIRAMATE 62 14 40 168
GLYBURIDE 62 54 R 40 69
CLONIDINE HCL 59 59 44 88
GABAPENTIN 58 54 45 18
TRAMADOL HCL 58 39 45 17
LOSARTAN POTASSIUM 58 58 45 20
LANTUS 55 38 48 38
NEXIUM 53 38 49 47
BENAZEPRIL HCL 52 40 50 39
PROAIR HFA 50 26 51 49
CARBIDOPA-LEVODOPA 50 20 51 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.